"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Skin will attain a temporary yellowish discoloration. Urine attains a bright yellow color.
Discoloration of the skin usually fades in 6 to 12 hours and usually fades in urine in 24 to 36 hours.
Last reviewed on RxList: 10/7/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Fluorescite Information
Report Problems to the Food and Drug Administration
Find out what women really need.